Killing arthritogenic fibroblast-like synoviocytes: an example using cytotoxic aptamers binding nucleolin
Abstract “Pauci-immune” and “fibroblast-rich” synovial pathotypes are predictors of resistance to multi-drug immunosuppression. For these “difficult-to-treat” (D2T) endotypes of rheumatoid arthritis (RA), depletion of arthritogenic fibroblast-like synoviocytes (FLS) has emerged as promising treatmen...
Saved in:
| Main Authors: | George D. Kalliolias, Efthimia K. Basdra, Athanasios G. Papavassiliou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Arthritis Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13075-025-03618-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytotoxic cationic peptides as а ligands for receptor nucleolin
by: A. A. Lushnikova, et al.
Published: (2018-11-01) -
Acylcarnitine enrichment as a characteristic of rheumatoid arthritis fibroblast-like synoviocyte metabolic fingerprint
by: Georgios K. Vasileiadis, et al.
Published: (2025-12-01) -
Unveiling the Therapeutic Potential: Targeting Fibroblast-like Synoviocytes in Rheumatoid Arthritis
by: Siran Yue, et al.
Published: (2025-01-01) -
Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis
by: Hongyan Qian, et al.
Published: (2024-05-01) -
Apurinic/apyrimidinic endonuclease 1 alleviates inflammation in fibroblast-like synoviocytes from patients with rheumatoid arthritis
by: Ha-Reum Lee, et al.
Published: (2024-08-01)